In conclusion, to the best of our knowledge, this is the first study to demonstrate expression of asprosin and its cognate receptor, OR4M1, in the human ovaries in health and cancer, focusing specifically on ovarian cancer. Here, OR4M1 is linked to ovarian cancer.